Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Ltd (NY: BHVN )

22.57 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 22.57
Bid (Size) 11.00 (1)
Ask (Size) 28.00 (10)
Prev. Close 22.57
Today's Range 22.57 - 22.57
52wk Range 7.100 - 152.56
Shares Outstanding 65,401,228
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Why Biohaven Stock Caught Fire This Week
Investors are excited about the company's recent progress. 
Via The Motley Fool

Performance

YTD
+67.19%
+67.19%
1 Month
+58.83%
+58.83%
3 Month
+60.41%
+60.41%
6 Month
+37.54%
+37.54%
1 Year
-84.43%
-84.43%

More News

Read More
How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run
Via Investor's Business Daily
Tower Semiconductor, XP And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Recap: Biohaven Q1 Earnings
Via Benzinga
Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns
Via Benzinga
Week In Review: HighlightLL Pharma Out-Licenses Parkinson's Treatment To Biohaven For $970 Million
Via Talk Markets
Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Via MarketBeat
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
Via Benzinga
Jim Cramer Says This Stock Up 23% In A Month Is 'A Great Speculative Buy'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
Via Benzinga
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
Via Benzinga
Jim Cramer Says This Stock Is Dynamite: 'I Do Not Want You To Do A Thing Other Than Ride It'
Via Benzinga
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Via Benzinga
$41 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying
Via Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Via Benzinga
Moderna, Amazon, Tesla, And Other Big Gainers From Friday
Via Benzinga
Intuitive Surgical, Netflix, ASML And Other Big Gainers From Wednesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Via Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.